Transgene S.A.
TRGNF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$33,971 | -$22,328 | -$32,804 | -$19,536 |
| Dep. & Amort. | $1,281 | $1,586 | $1,686 | $2,521 |
| Deferred Tax | $0 | $0 | $0 | -$1,031 |
| Stock-Based Comp. | $568 | $290 | $2,675 | $4,658 |
| Change in WC | $10,753 | -$7,065 | $5,090 | -$12,798 |
| Other Non-Cash | -$2,179 | -$7,154 | $3,050 | -$4,101 |
| Operating Cash Flow | -$23,548 | -$34,671 | -$20,303 | -$31,943 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$3,075 | -$2,746 | -$1,535 | -$686 |
| Net Acquisitions | $0 | $14,345 | $0 | $17,193 |
| Inv. Purchases | $0 | $0 | $0 | -$40,000 |
| Inv. Sales/Matur. | $0 | $22,641 | $21,807 | $17,479 |
| Other Inv. Act. | -$131 | $332 | $21,769 | $22,807 |
| Investing Cash Flow | -$3,206 | $34,572 | $20,272 | $16,793 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $28,650 | $12,859 | $0 | -$197 |
| Stock Issued | $0 | $0 | $0 | $34,129 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$1,691 | -$1,490 | -$1,477 | -$1,612 |
| Financing Cash Flow | $26,959 | $11,369 | -$1,477 | $15,772 |
| Forex Effect | $799 | -$7 | $0 | $12 |
| Net Chg. in Cash | $1,004 | $11,263 | -$1,508 | $634 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $15,666 | $4,403 | $5,911 | $5,277 |
| End Cash | $16,670 | $15,666 | $4,403 | $5,911 |
| Free Cash Flow | -$26,623 | -$37,417 | -$21,838 | -$32,629 |